Yesterday, Tuesday 18 March, Alzheimer’s Society unveiled its first ever Launchpad Cohort. Their original ideas will address a broad range of challenges people living with dementia face, including tackling some of the main issues connected to hospitalisation.

We respond to the disappointing decision NICE has made to not recommend donanemab and lecanemab on the NHS.

One of our dementia experts gives advice on spotting the signs of young-onset dementia, following actor and Alzheimer's Society supporter Anne-Marie Duff's appearance on BBC Breakfast.

Widespread confusion over dementia symptoms vs signs of old age discovered in Alzheimer’s Society research, launched ahead Dementia Action Week (15-21 May) in 2023.

Today the dementia diagnosis rate target (that 66.7% of people living with dementia in England should have a diagnosis) has been removed from the NHS Operational Planning Guidance for 2025-6.